Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kodiak Sciences Inc. (KOD)  
$3.61 0.19 (5%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 44,800,000
Market Cap: 161.73(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.4 - $9.48
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Kodiak Sciences is a biopharmaceutical company focused on researching, developing and commercializing therapeutics to treat high prevalence retinal diseases. Co.'s Antibody Biopolymer Conjugate Platform™ uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies. Co.'s main product candidate, KSI-301, is an anti-vascular endothelial growth factor antibody biopolymer conjugate for the treatment in retinal vascular diseases including wet age-related macular degeneration (AMD), diabetic macular edema and retinal vein occlusion. Co.'s pipeline, including product candidates KSI-501 and KSI-601, are used for other needs in retina such as dry AMD and glaucoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,379,445
Total Buy Value $0 $0 $0 $9,508,745
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 9
Total Shares Sold 0 0 7,587 15,417
Total Sell Value $0 $0 $70,517 $126,006
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 4 8
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 153
  Page 2 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baker Felix Director   –       •       •   2022-02-17 4 B $53.82 $16,367,881 I/I 300,000 14,734,965 2.25 -85%     
   Baker Felix Director   –       •       •   2022-02-16 4 B $53.73 $5,150,173 I/I 95,165 14,457,794 2.25 -86%     
   Baker Felix Director   –       •       •   2022-02-15 4 B $54.16 $314,099 I/I 5,800 14,369,871 2.25 -85%     
   Baker Felix Director   –       •       •   2022-01-31 4 B $57.22 $1,725,084 I/I 30,148 14,364,512 2.25 -86%     
   Baker Felix Director   –       •       •   2022-01-28 4 B $49.70 $2,786,084 I/I 55,258 14,336,671 2.25 -83%     
   Baker Felix Director   –       •       •   2022-01-27 4 B $51.59 $13,573,519 I/I 262,259 14,285,631 2.25 -83%     
   Baker Felix Director   –       •       •   2022-01-25 4 B $58.90 $323,934 I/I 5,500 14,027,837 2.25 -87%     
   Baker Felix Director   –       •       •   2022-01-24 4 B $56.39 $20,905,291 I/I 362,197 14,022,337 2.25 -87%     
   Baker Felix Director   –       •       •   2022-01-21 4 B $56.57 $7,577,571 I/I 133,414 13,660,140 2.25 -87%     
   Ehrlich Jason See Remarks   •       –      –    2022-01-20 4 AS $62.72 $447,494 D/D (6,950) 51,541 -88%     
   Ehrlich Jason See Remarks   •       –      –    2022-01-20 4 OE $10.29 $71,516 D/D 6,950 58,491     -
   Ehrlich Jason See Remarks   •       –      –    2021-12-20 4 AS $86.60 $608,831 D/D (6,950) 51,541 -93%     
   Ehrlich Jason See Remarks   •       –      –    2021-12-20 4 OE $10.29 $71,516 D/D 6,950 58,491     -
   Ehrlich Jason See Remarks   •       –      –    2021-11-22 4 AS $96.82 $689,113 D/D (6,950) 51,541 -92%     
   Ehrlich Jason See Remarks   •       –      –    2021-11-22 4 OE $10.29 $71,516 D/D 6,950 58,491     -
   Borgeson John A. See Remarks   •       –      –    2021-11-10 4 AS $115.16 $101,111 D/D (876) 169,443 -93%     
   Ehrlich Jason See Remarks   •       –      –    2021-10-20 4 AS $111.56 $776,824 D/D (6,950) 51,541 -92%     
   Ehrlich Jason See Remarks   •       –      –    2021-10-20 4 OE $10.29 $71,516 D/D 6,950 58,491     -
   Baker Julian Director   –       •       •   2021-09-30 4 B $95.83 $8,330,572 I/I 86,932 13,526,726 2.25 -38%     
   Baker Julian Director   –       •       •   2021-09-29 4 D $102.00 $1,632 I/I (16) 13,439,794     -
   Baker Julian Director   –       •       •   2021-09-29 4 OE $0.01 $1,500 I/I 149,999 13,439,808     -
   Ehrlich Jason See Remarks   •       –      –    2021-09-20 4 AS $99.74 $694,164 D/D (6,950) 51,541 -41%     
   Ehrlich Jason See Remarks   •       –      –    2021-09-20 4 OE $10.29 $71,516 D/D 6,950 58,491     -
   Baker Julian Director   –       •       •   2021-09-16 4 B $94.59 $109,064 I/I 1,153 13,300,993 2.25 -47%     
   Baker Julian Director   –       •       •   2021-09-15 4 B $94.38 $2,896,216 I/I 30,685 13,299,840 2.25 -42%     
  153 Records found
  1  2  3  4  5  6  7   
  Page 2 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us